Almirall predicts positive 2021 development of psoriasis product
![Photo: Mikkel Aabenhus Hemmingsen / MedWatch](https://photos.watchmedier.dk/watchmedier/resize:fill:3840:0:0/plain/https://photos.watchmedier.dk/Images/article12778398.ece/ALTERNATES/schema-16_9/doc7emfviqkbwg2n71toox.jpg)
In early 2020, already, Almirall warned this wouldn't be the best year. Competition from US generic products would have a severe impact, and the firm was facing a series of investments.
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.